Parlodel is a brand name of bromocriptine, approved by the FDA in the following formulation(s):
PARLODEL (bromocriptine mesylate - capsule; oral)
Manufacturer: NOVARTIS
Approval date: March 1, 1982
Strength(s): EQ 5MG BASE [RLD][AB]
PARLODEL (bromocriptine mesylate - tablet; oral)
Manufacturer: NOVARTIS
Approved Prior to Jan 1, 1982
Strength(s): EQ 2.5MG BASE [RLD][AB]
Has a generic version of Parlodel been approved?
Yes. The following products are equivalent to Parlodel:
bromocriptine mesylate capsule; oral
Manufacturer: MYLAN
Approval date: April 4, 2005
Strength(s): EQ 5MG BASE [AB]
Manufacturer: ZYDUS PHARMS USA INC
Approval date: July 30, 2008
Strength(s): EQ 5MG BASE [AB]
bromocriptine mesylate tablet; oral
Manufacturer: LEK PHARMS
Approval date: January 13, 1998
Strength(s): EQ 2.5MG BASE [AB]
Manufacturer: MYLAN
Approval date: September 24, 2004
Strength(s): EQ 2.5MG BASE [AB]
Manufacturer: PADDOCK LLC
Approval date: October 1, 2008
Strength(s): EQ 2.5MG BASE [AB]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Parlodel. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with Parlodel.
See also...
- Parlodel Consumer Information (Wolters Kluwer)
- Parlodel Consumer Information (Cerner Multum)
- Parlodel Advanced Consumer Information (Micromedex)
- Parlodel AHFS DI Monographs (ASHP)
- Bromocriptine Consumer Information (Wolters Kluwer)
- Bromocriptine Mesylate Consumer Information (Wolters Kluwer)
- Bromocriptine Consumer Information (Cerner Multum)
- Bromocriptine Advanced Consumer Information (Micromedex)
- Bromocriptine Mesylate AHFS DI Monographs (ASHP)
No comments:
Post a Comment